EUVIMEDSkopri EUVIMED
Crossref

A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation

Mohamed A El Hamd iD, Osama M Soltan, Kamal S Abdelrahman, Wejdan T Alsaggaf, Ahmed A Abu-Hassan iD

Luminescence · 2023

DOI: 10.1002/bio.4502 ↗

At a glance

Journal article in Luminescence, 2023. Written by Mohamed A El Hamd and 4 co-authors. Institution: Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia. Major MEDLINE topics: Sitagliptin Phosphate, Metformin. Cited 10 times so far (Crossref); 46 references. Funded by: Deanship of Scientific Research at Shaqra University.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Dipeptidyl peptidase‐4 enzyme suppressant is a unique category of oral antidiabetic medication. Sitagliptin (STG) is a perfect member of this category and is pharmaceutically marketed alone or in combination with metformin. Here, the ideal application of an isoindole derivative for STG assay was developed using a feasible, easy‐to‐use, economic, and affordable method. STG as an amino group donor can form a luminescent derivative: isoindole on interaction with o ‐phthalaldehyde and the existence of (2‐mercaptoethanol) 0.02% (v/v) as a thiol group donor. Excitation (339.7 nm) and emission (434.6 nm) wavelengths were used to monitor the isoindole fluorophore yield; moreover, each experimental variable was carefully investigated and adjusted. The calibration graph was constructed by plotting fluorescence intensities against STG concentrations, and controlled linearity was observed at concentrations ranging from 50 to 1000 ng/ml. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use guidelines were analyzed in depth to prove the technique validation. The implementation of the present technique was extended successfully to the evaluation of various types of STG dose forms and spiking samples of human plasma and urine. The developed technique was shown to be an effective, simple, and quick replacement for quality control and clinical study evaluation of STG.

Subjects

MeSH terms (MEDLINE)

Sitagliptin PhosphateMetforminHumanso-PhthalaldehydeHypoglycemic AgentsSulfhydryl CompoundsSpectrometry, Fluorescence

Author keywords

biological fluidisoindole derivativeo-phthalaldehydesitagliptinspectrofluorimetric

Substances

Sitagliptin Phosphateo-PhthalaldehydeHypoglycemic AgentsSulfhydryl CompoundsMetformin

Authors and institutions

  • Department of Pharmaceutical Sciences, College of Pharmacy, Shaqra University, Shaqra, Saudi Arabia.
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, South Valley University, Qena, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut, Egypt.
  • Department of Chemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Al-Azhar University, Assiut Branch, Assiut, Egypt.

ORCID profiles: Mohamed A El Hamd, Ahmed A Abu-Hassan

Funding

  • Deanship of Scientific Research at Shaqra University

Cite

APA

El Hamd, M. A., Soltan, O. M., Abdelrahman, K. S., Alsaggaf, W. T., & Abu-Hassan, A. A. (2023). A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation. Luminescence. https://doi.org/10.1002/bio.4502

Vancouver

El Hamd MA, Soltan OM, Abdelrahman KS, Alsaggaf WT, Abu-Hassan AA. A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation. Luminescence. 2023. doi:10.1002/bio.4502

BibTeX
@article{ElHamd2023,
  author = {El Hamd, Mohamed A and Soltan, Osama M and Abdelrahman, Kamal S and Alsaggaf, Wejdan T and Abu-Hassan, Ahmed A},
  title = {A new application of isoindole fluorophore derivative in sitagliptin antidiabetic medication assay: Application to dosage forms and biological fluid evaluation},
  journal = {Luminescence},
  year = {2023},
  doi = {10.1002/bio.4502}
}
Start for free →